This follows last week's recommendation from a government panel that
J&J pay at least 2 million rupees ($27,812) to each patient for the
faulty ASR hip implant. The federal government has asked states to
help patients get relief soon.
About 93,000 people worldwide received ASR implants which were
recalled in 2010. The Indian panel said in its report that about
4,700 of those people were in India.
Given the recent committee report, "we are seeking to work with the
Indian government to develop an appropriate process for providing
further support and compensation for patients in need", a J&J
spokeswoman said in a statement to Reuters, adding the firm was
committed to support all ASR patients in India.
Sushobhan Dasgupta, a senior J&J executive in India, has, however,
told Indian newspaper Mint that the company "will not pay people who
had an ASR implant if they are doing well".
The company is not okay with the methodology used by the Indian
panel, Dasgupta told the paper in an interview
published on Friday. The report has "factual inaccuracies" and "the
conclusions could also be inaccurate", he added.
[to top of second column]
In 2013, J&J agreed to pay http://reut.rs/I20AZB nearly $2.5 billion
to settle thousands of lawsuits from patients in the United States
who said they were injured by the implants.
In India, the company paid $2 million to patients for repeat
surgeries and about $250,000 in related diagnostic costs under its
ASR reimbursement program, but the government panel has criticized
J&J for offering no compensation.
Metal hip implant systems such as ASR were designed to be more
durable than a traditional metal-on-plastic, ball-and-socket design.
But many Indian patients suffered adverse reactions to the implant,
the panel said.
J&J entered the Indian market in 1947 when it started selling its
now-ubiquitous baby powder. It has in recent years faced issues such
as price caps on medical devices.
($1 = 71.9100 Indian rupees)
(Reporting by Aditya Kalra, Writing by Krishna N. Das; Editing by
Darren Schuettler and Himani Sarkar)
[© 2018 Thomson Reuters. All rights
Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.